Femasys announces financial results for year ended december 31, 2023 and provides corporate update

Following fda clearance of femaseed®, company secures capital to support commercial initiatives; cash expected to fund operations into 2h 2025 following fda clearance of femaseed®, company secures capital to support commercial initiatives; cash expected to fund operations into 2h 2025
FEMY Ratings Summary
FEMY Quant Ranking